Cho, J.J.* ; Xu, Z.* ; Parthasarathy, U.* ; Drashansky, T.T.* ; Helm, E.Y.* ; Zuniga, A.N.* ; Lorentsen, K.J.* ; Mansouri, S.* ; Cho, J.Y.* ; Edelmann, M.J.* ; Duong, D.M.* ; Gehring, T. ; Seeholzer, T. ; Krappmann, D. ; Uddin, M.N.* ; Califano, D.* ; Wang, R.L.* ; Jin, L.* ; Li, H.* ; Lv, D.* ; Zhou, D.* ; Zhou, L.* ; Avram, D.*
Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation.
Nat. Commun. 10:701 (2019)
Polyubiquitination promotes proteasomal degradation, or signaling and localization, of targeted proteins. Here we show that the E3 ubiquitin ligase Hectd3 is necessary for pathogenic Th17 cell generation in experimental autoimmune encephalomyelitis (EAE), a mouse model for human multiple sclerosis. Hectd3-deficient mice have lower EAE severity, reduced Th17 program and inefficient Th17 cell differentiation. However, Stat3, but not ROR gamma t, has decreased polyubiquitination, as well as diminished tyrosine-705 activating phosphorylation. Additionally, non-degradative polyubiquitination of Malt1, critical for NF-kappa B activation and Th17 cell function, is reduced. Mechanistically, Hectd3 promotes K27-linked and K29-linked polyubiquitin chains on Malt1, and K27-linked polyubiquitin chains on Stat3. Moreover, Stat3 K180 and Malt1 K648 are targeted by Hectd3 for non-degradative polyubiquitination to mediate robust generation of ROR gamma t+ IL-17A(hi) effector CD4(+) T cells. Thus, our studies delineate a mechanism connecting signaling related polyubiquitination of Malt1 and Stat3, leading to NF-kB activation and ROR gamma t expression, to pathogenic Th17 cell function in EAE.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Ror-gamma-t; Nf-kappa-b; Growth-factor-beta; Paracaspase Malt1; T-h-17 Cells; Interleukin-17 Production; Gene-expression; T(h)17 Cells; Ubiquitin; Receptor
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2019
Prepublished im Jahr
HGF-Berichtsjahr
2019
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 10,
Heft: 1,
Seiten: ,
Artikelnummer: 701
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
Research Unit Signaling and Translation (SAT)
POF Topic(s)
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-509800-002
Förderungen
Copyright
Erfassungsdatum
2019-03-13